PFAS ‘Forever Chemicals’ in Fetal Blood: New Research Reveals Higher Levels Than Thought

The developing world inside the womb may be facing a greater chemical burden than previously understood. New research suggests that fetuses are exposed to a significantly wider range of PFAS – often called “forever chemicals” – than current standard testing methods reveal. These compounds, linked to a growing list of health concerns, are ubiquitous in the environment and human bodies, and this finding underscores the challenges in fully assessing their impact on early development.

Beyond PFOA and PFOS: A Broader Appear at PFAS Exposure

For years, testing of umbilical cord blood has largely focused on two well-known PFAS compounds: perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). These were among the first PFAS identified as problematic and have been phased out of production in many countries. However, thousands of other PFAS exist, and a recent study from Mount Sinai’s Icahn School of Medicine has expanded the scope of analysis. Researchers re-examined 120 previously tested umbilical cord blood samples, initially analyzed for up to four PFAS compounds, using a more comprehensive “non-targeted analysis” capable of identifying thousands.

The results, published as peer-reviewed research, revealed 42 different PFAS compounds present across the samples. Crucially, the total level of PFAS detected was considerably higher than previous assessments indicated. “It’s particularly important to understand because This proves a very vulnerable period when fetuses are exposed,” explained Shelley Liu, a study co-author and associate professor at Mount Sinai, in reporting on the findings. This suggests that babies are absorbing a far more complex mixture of these chemicals than previously appreciated.

What are PFAS and Why are They a Concern?

PFAS are a class of approximately 15,000 chemicals used in a vast array of consumer and industrial products. Their ability to repel water, oil, and grease makes them valuable in non-stick cookware, stain-resistant fabrics, firefighting foams, and food packaging, among other applications. However, this same chemical stability also means they don’t break down easily in the environment or the human body – hence the moniker “forever chemicals.”

The health implications of PFAS exposure are increasingly concerning. Research has linked these chemicals to a range of adverse health outcomes, including certain types of cancer, birth defects, decreased immune response, elevated cholesterol levels, kidney disease, and other serious health problems. A review of 40 studies found that researchers had detected PFAS in all 30,000 umbilical cord blood samples they examined. Elevated PFAS levels in mothers have been associated with higher infant mortality rates, as well as low birth weight and obesity later in life. Fetal exposure has also been linked to potential neurological and cardiovascular issues.

The Shift to Newer PFAS and Regulatory Challenges

While the “legacy” PFAS like PFOA and PFOS have been largely phased out, manufacturers have replaced them with newer generations of PFAS. These replacements are often touted as less toxic, but evidence supporting these claims is frequently limited. PFAS can break down into other compounds within the environment and the human body, adding to the complexity of assessing their overall impact.

Regulatory efforts to monitor and mitigate PFAS contamination face significant hurdles. Current testing methods often lag behind the evolving chemical landscape. For example, the US Environmental Protection Agency (EPA) typically tests water samples for around 30-40 PFAS compounds, despite the fact that thousands have been identified in water sources by independent researchers. A 2022 analysis by The Guardian found that regulators frequently undercounted PFAS levels in water due to these limitations.

The Mount Sinai study highlights this issue directly, demonstrating that the broader “non-targeted” analysis consistently detected more PFAS than the traditional, more limited testing approach. The EPA has recently certified a blood test that checks for 53 compounds, representing an improvement, but the Mount Sinai analysis still identified 31 compounds not included in the EPA’s expanded list.

What Does This Signify for Babies’ Health?

While the study definitively shows increased PFAS exposure, the direct health consequences for babies remain unclear. Liu noted that the impact is “kind of unclear,” but generally, higher levels of PFAS in the bloodstream are associated with increased health risks. The researchers are now leveraging data from the federal government’s Home study – a long-term study tracking PFAS exposure and health outcomes – to investigate potential links between early-life exposure and later-life health problems.

David Andrews, acting chief science officer with the Environmental Working Group (EWG), emphasized that the study underscores how the full extent of harm from PFAS exposure to infants has likely been underestimated. “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as Pfas,” Andrews added.

The Path Forward: Enhanced Monitoring and Regulation

The findings from Mount Sinai and other ongoing research are driving a re-evaluation of PFAS monitoring and regulation. The EPA is currently working on establishing national drinking water standards for several PFAS compounds, and is also considering designating certain PFAS as hazardous substances under the Superfund law, which could compel responsible parties to clean up contaminated sites. However, the sheer number of PFAS compounds and their widespread presence in the environment present ongoing challenges.

Further research is needed to fully understand the health effects of different PFAS compounds, particularly in vulnerable populations like developing fetuses. Improved testing methods, like the “non-targeted” analysis used in the Mount Sinai study, are crucial for accurately assessing exposure levels. Reducing PFAS contamination at the source – by phasing out unnecessary uses and developing safer alternatives – will be essential to protecting public health.

What to expect in the coming months: The EPA is expected to finalize its national drinking water standards for PFAS in the coming year. Ongoing research, including analyses from the Home study, will continue to shed light on the long-term health effects of PFAS exposure. Consumers can stay informed about PFAS contamination in their local communities by checking updates from state and local environmental agencies.